These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 35041395)
1. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy. Li K; Lin C; Li M; Xu K; He Y; Mao Y; Lu L; Geng W; Li X; Luo Z; Cai K ACS Nano; 2022 Feb; 16(2):2381-2398. PubMed ID: 35041395 [TBL] [Abstract][Full Text] [Related]
2. Curcumin Induces Ferroptosis in A549 CD133 Zhou J; Zhang L; Yan J; Hou A; Sui W; Sun M Discov Med; 2023 Jun; 35(176):251-263. PubMed ID: 37272092 [TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer. Chen T; Leng J; Tan J; Zhao Y; Xie S; Zhao S; Yan X; Zhu L; Luo J; Kong L; Yin Y J Med Chem; 2023 Jul; 66(14):10036-10059. PubMed ID: 37452764 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis. Jelinek A; Heyder L; Daude M; Plessner M; Krippner S; Grosse R; Diederich WE; Culmsee C Free Radic Biol Med; 2018 Mar; 117():45-57. PubMed ID: 29378335 [TBL] [Abstract][Full Text] [Related]
6. FSP1 is a glutathione-independent ferroptosis suppressor. Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899 [TBL] [Abstract][Full Text] [Related]
7. Acetaminophen impairs ferroptosis in the hippocampus of septic mice by regulating glutathione peroxidase 4 and ferroptosis suppressor protein 1 pathways. Chu J; Li H; Yuan Z; Zhou W; Yu Y; Yu Y Brain Behav; 2023 Aug; 13(8):e3145. PubMed ID: 37443407 [TBL] [Abstract][Full Text] [Related]
8. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib. Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851 [TBL] [Abstract][Full Text] [Related]
9. Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy. Yang N; Pan X; Zhou X; Liu Z; Yang J; Zhang J; Jia Z; Shen Q Adv Healthc Mater; 2024 Mar; 13(7):e2302752. PubMed ID: 37975280 [TBL] [Abstract][Full Text] [Related]
10. Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer. Li J; Wu Y; Li Y; Zhu H; Zhang Z; Li Y ACS Nano; 2024 Oct; 18(39):26585-26599. PubMed ID: 39287044 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε. Vučković AM; Bosello Travain V; Bordin L; Cozza G; Miotto G; Rossetto M; Toppo S; Venerando R; Zaccarin M; Maiorino M; Ursini F; Roveri A FEBS Lett; 2020 Feb; 594(4):611-624. PubMed ID: 31581313 [TBL] [Abstract][Full Text] [Related]
12. Metabolic Intervention Nanoparticles for Triple-Negative Breast Cancer Therapy via Overcoming FSP1-Mediated Ferroptosis Resistance. Yang J; Jia Z; Zhang J; Pan X; Wei Y; Ma S; Yang N; Liu Z; Shen Q Adv Healthc Mater; 2022 Jul; 11(13):e2102799. PubMed ID: 35395704 [TBL] [Abstract][Full Text] [Related]
13. Ferroptosis Inducers in Thyroid Cancer. Sekhar KR; Cyr S; Baregamian N World J Surg; 2023 Feb; 47(2):371-381. PubMed ID: 36195678 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma. Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648 [TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis. Ni W; Li Y; Liang L; Yang S; Zhan M; Lu C; Lu L; Wen L J Biomed Nanotechnol; 2022 Feb; 18(2):327-342. PubMed ID: 35484753 [TBL] [Abstract][Full Text] [Related]
16. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900 [TBL] [Abstract][Full Text] [Related]
17. Identification of a Small Molecule That Enhances Ferroptosis via Inhibition of Ferroptosis Suppressor Protein 1 (FSP1). Yoshioka H; Kawamura T; Muroi M; Kondoh Y; Honda K; Kawatani M; Aono H; Waldmann H; Watanabe N; Osada H ACS Chem Biol; 2022 Feb; 17(2):483-491. PubMed ID: 35128925 [TBL] [Abstract][Full Text] [Related]
18. Improved Immune Response for Colorectal Cancer Therapy Triggered by Multifunctional Nanocomposites with Self-Amplifying Antitumor Ferroptosis. Lin X; Chen H; Deng T; Cai B; Xia Y; Xie L; Wang H; Huang C ACS Appl Mater Interfaces; 2024 Mar; 16(11):13481-13495. PubMed ID: 38456402 [TBL] [Abstract][Full Text] [Related]
19. Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells. Gotorbe C; Durivault J; Meira W; Cassim S; Ždralević M; Pouysségur J; Vučetić M Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552620 [TBL] [Abstract][Full Text] [Related]
20. Photothermal-Enhanced Inactivation of Glutathione Peroxidase for Ferroptosis Sensitized by an Autophagy Promotor. An P; Gao Z; Sun K; Gu D; Wu H; You C; Li Y; Cheng K; Zhang Y; Wang Z; Sun B ACS Appl Mater Interfaces; 2019 Nov; 11(46):42988-42997. PubMed ID: 31650832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]